Search

Gregory G Podsakoff

from Los Angeles, CA
Age ~44
Get Report
Also known as:
Gregory F, Greg F
Related to:
Greg PodsakoffRosie PodsakoffEfosinia PodsakoffJames Pattie, 64Efrosinia Podsakoff
Connected to:
Kurt M Podschlne, 55Margaret A Podschweit, 64Misty D Podschun, 43David L Podsednik, 66Katie Podshivalova, 40Alicia A Podsiadly, 56Andrew S Podsiadlo, 49Magdalena K Podsiadlo, 35Mike J Podsiadlo, 41Walter A Podsiedlak, 75

Gregory Podsakoff Phones & Addresses

  • Los Angeles, CA
  • Whittier, CA
  • 1227 Ocean Blvd, Long Beach, CA 90802
  • Ridgecrest, CA
  • 2832 Teal Dr, Fullerton, CA 92835 (714) 996-9029
  • Carlsbad, CA

Professional Records

Medicine Doctors

Gregory Podsakoff Photo 1

Gregory M Podsakoff

View page
Specialties:
Internal Medicine
Education:
Loma Linda University (1977)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Gregory G. Podsakoff
President
TERRA GLACE, INC
Nonclassifiable Establishments
1227 E Ocean Blvd APT 401, Long Beach, CA 90802

Publications

Us Patents

Methods For Delivering Dna To Muscle Cells Using Recombinant Adeno-Associated Virus Virions To Treat Lysosomal Storage Disease

View page
US Patent:
6335011, Jan 1, 2002
Filed:
Sep 28, 1999
Appl. No.:
09/406362
Inventors:
Gregory M. Podsakoff - Fullerton CA
Paul D. Kessler - Baltimore MD
Barry J. Byrne - Baltimore MD
Gary J. Kurtzman - Menlo Park CA
Assignee:
Avigen, Inc. - Alameda CA
Johns Hopkins University - Baltimore MD
International Classification:
A01N 6300
US Classification:
424 932, 424 936, 514 44, 4353201
Abstract:
The use of recombinant adeno-associated virus (AAV) virions for delivery of DNA molecules to muscle cells and tissue is disclosed. The invention allows for the direct, in vivo injection of recombinant AAV virions into muscle tissue, e. g. , by intramuscular injection, as well as for the in vitro transduction of muscle cells which can subsequently be introduced into a subject for treatment. The invention provides for sustained, high-level expression of the delivered gene and for in vivo secretion of the therapeutic protein from transduced muscle cells such that systemic delivery is achieved.

Methods For Delivering Dna To The Bloodstream Using Recombinant Adeno-Associated Virus Vectors

View page
US Patent:
6391858, May 21, 2002
Filed:
Jan 4, 2001
Appl. No.:
09/755734
Inventors:
Gregory M. Podsakoff - Fullerton CA
Gary J. Kurtzman - Menlo Park CA
Assignee:
Avigen, Inc. - Alameda CA
International Classification:
A61K 4800
US Classification:
514 44, 4353201, 4352351, 435 691, 435371
Abstract:
The use of recombinant adeno-associated virus (AAV) virions for delivery of DNA molecules to muscle cells and tissue is disclosed. The invention allows for the direct, in vivo injection of recombinant AAV virions into muscle tissue, e. g. , by intramuscular injection, as well as for the in vitro transduction of muscle cells which can subsequently be introduced into a subject for treatment. The invention provides for sustained, high-level expression of the delivered gene and for in vivo secretion of the therapeutic protein from transduced muscle cells such that systemic delivery is achieved.

Recombinant Adeno-Associated Virus Virions For The Treatment Of Lysosomal Disorders

View page
US Patent:
6582692, Jun 24, 2003
Filed:
Nov 17, 2000
Appl. No.:
09/715858
Inventors:
Gregory Podsakoff - Fullerton CA
Gordon Watson - El Sobrante CA
Assignee:
Avigen, Inc. - Alameda CA
Childrens Hospital Medical Center of Northern California - Oakland CA
International Classification:
A01N 6300
US Classification:
424 932, 4353201, 435455, 514 44
Abstract:
AAV expression vectors and recombinant virions produced using these vectors, which include genes coding for enzymes defective or missing in lysosomal storage disorders, are described. These recombinant AAV virions are useful in the treatment of a variety of lysosomal storage disorders and the methods described herein provide for long-term, sustained expression of the defective or missing enzyme.

Adeno Associated Virus Vectors For The Treatment Of A Cardiomyopathy

View page
US Patent:
6610290, Aug 26, 2003
Filed:
Oct 1, 2001
Appl. No.:
09/969204
Inventors:
Gregory M. Podsakoff - Fullerton CA
Paul D. Kessler - Baltimore MD
Barry J. Byrne - Baltimore MD
Gary J. Kurtzman - Menlo Park CA
Assignee:
Avigen, Inc. - Alameda CA
Johns Hopkins University - Baltimore MD
International Classification:
A01N 6300
US Classification:
424 932, 424 936, 514 44, 4353201
Abstract:
The use of recombinant adeno-associated virus (AAV) virions for delivery of DNA molecules to muscle cells and tissue is disclosed. The invention allows for the direct, in vivo injection of recombinant AAV virions into muscle tissue, e. g. , by intramuscular injection, as well as for the in vitro transduction of muscle cells which can subsequently be introduced into a subject for treatment. The invention provides for sustained, high-level expression of the delivered gene and for in vivo secretion of the therapeutic protein from transduced muscle cells such that systemic delivery is achieved.

Methods For Delivering Dna To Muscle Cells Using Recombinant Adeno-Associated Virus Vectors

View page
US Patent:
7238674, Jul 3, 2007
Filed:
Mar 5, 2002
Appl. No.:
10/092454
Inventors:
Gregory M. Podsakoff - Fullerton CA, US
Paul D. Kessler - Baltimore MD, US
Barry J. Byrne - Baltimore MD, US
Gary J. Kurtzman - Menlo Park CA, US
Assignee:
Genzyme Corporation - Cambridge MA
International Classification:
A61K 48/00
C12N 5/00
C12N 15/63
C12N 15/87
US Classification:
514 44, 4353201, 435325, 435455, 424 932, 424 931
Abstract:
The use of recombinant adeno-associated virus (AAV) virions for delivery of DNA molecules to muscle cells and tissue is disclosed. The invention allows for the direct, in vivo injection of recombinant AAV virions into muscle tissue, e. g. , by intramuscular injection, as well as for the in vitro transduction of muscle cells which can subsequently be introduced into a subject for treatment. The invention provides for sustained, high-level expression of the delivered gene and for in vivo secretion of the therapeutic protein from transduced muscle cells such that systemic delivery is achieved.

Methods For Delivering Dna To Muscle Cells Using Recombinant Adeno-Associated Virus Virions

View page
US Patent:
7704492, Apr 27, 2010
Filed:
Jul 15, 2008
Appl. No.:
12/218394
Inventors:
Gregory M. Podsakoff - Fullerton CA, US
Paul D. Kessler - Baltimore MD, US
Barry J. Byrne - Baltimore MD, US
Gary J. Kurtzman - Menlo Park CA, US
Assignee:
Genzyme Corporation - Cambridge MA
International Classification:
A61K 48/00
C12N 15/00
US Classification:
424 932, 514 44, 4353201
Abstract:
The use of recombinant adeno-associated virus (AAV) virions for delivery of DNA molecules to muscle cells and tissue is disclosed. The invention allows for the direct, in vivo injection of recombinant AAV virions into muscle tissue, e. g. , by intramuscular injection, as well as for the in vitro transduction of muscle cells which can subsequently be introduced into a subject for treatment. The invention provides for sustained, high-level expression of the delivered gene and for in vivo secretion of the therapeutic protein from transduced muscle cells such that systemic delivery is achieved.

Methods Of Treating Anemia Using Recombinant Adeno-Associated Virus Virions

View page
US Patent:
20030206889, Nov 6, 2003
Filed:
Jun 10, 2003
Appl. No.:
10/458857
Inventors:
Gregory Podsakoff - Fullerton CA, US
Gary Kurtzman - Menlo Park CA, US
International Classification:
A61K048/00
C12N015/861
US Classification:
424/093200, 435/456000
Abstract:
The use of recombinant adeno-associated virus (AAV) virions for delivery of DNA molecules to muscle cells and tissue in the treatment of anemia is disclosed. The invention allows for the direct, in vivo injection of recombinant AAV virions into muscle tissue, e.g., by intramuscular injection, as well as for the in vitro transduction of muscle cells which can subsequently be introduced into a subject for treatment. The invention provides for sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery is achieved.

Recombinant Adeno-Associated Virus Virions For The Treatment Of Lysosomal Disorders

View page
US Patent:
20030219414, Nov 27, 2003
Filed:
Apr 22, 2003
Appl. No.:
10/421175
Inventors:
Gregory Podsakoff - Fullerton CA, US
Gordon Watson - El Sobrante CA, US
Linda Couto - Pleasanton CA, US
Bin Yang - Castro Valley CA, US
International Classification:
A61K048/00
C12N015/861
US Classification:
424/093200, 435/456000
Abstract:
AAV expression vectors and recombinant virions produced using these vectors, which include genes coding for enzymes defective or missing in lysosomal storage disorders, are described. These recombinant AAV virions are useful in the treatment of a variety of lysosomal storage disorders and the methods described herein provide for long-term, sustained expression of the defective or missing enzyme.
Control profile
Gregory G Podsakoff from Los Angeles, CA, age ~44 Get Report